Last month Bovie dealt its core business, including the Bovie brand, to Symmetry Surgical for $97 million. The all-cash sale augured a pivot for Clearwater, Fla.-based Bovie toward the cosmetic surgery market with its J-Plasma and Renuvion brands.
Today Bovie said it expects to post net losses of -$12.7 million to -$12.3 million on sales of $15.2 million to $15.6 million.
The news sent BVX shares down -5.4% to $5.85 apiece today in pre-market trading.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.